Risk/Benefit Assessment of β-Blockers and Diuretics Precludes Their Use for First-Line Therapy in Hypertension-Reference-Cited by-同舟云学术

Risk/Benefit Assessment of β-Blockers and Diuretics Precludes Their Use for First-Line Therapy in Hypertension

Published:2008-05-20 Issue:20 Volume:117 Page:2706-2715
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Messerli Franz H.¹,Bangalore Sripal¹,Julius Stevo¹

Affiliation:

1. From the Department of Medicine, Division of Cardiology, St Luke’s–Roosevelt Hospital and Columbia University College of Physicians and Surgeons, New York, NY (F.H.M., S.B.), and the Department of Internal Medicine, University of Michigan, Ann Arbor (S.J.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.107.695007

Reference46 articles.

1. Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure

2. The 1984 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure

3. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 Report

4. CDC’s Diabetes Program. National Diabetes Surveillance System: prevalence of diabetes. Available at: http://www.ede.gov/diabetes/statistics/prev/national/source.htm. Accessed January 8 2007.

5. Hypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes Mellitus

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A cost-benefit analysis of beta-blockers, including the benefits of reducing the symptoms of dementia;Applied Economics;2024-02-14

2. Potassium Magnesium Citrate Is Superior to Potassium Chloride in Reversing Metabolic Side Effects of Chlorthalidone;Hypertension;2023-12

3. Double-Trouble: Atherosclerotic Risk Factors and Congenital Heart Disease;Current Atherosclerosis Reports;2023-06-12

4. The role of dietary salt in metabolism and energy balance: Insights beyond cardiovascular disease;Diabetes, Obesity and Metabolism;2023-02-28

5. Beta-blockers in the prevention and treatment of ischemic heart disease: Evidence and clinical practice;Heart Views;2023